Back
ESC2025 Premium Access

Effect of glucagon-like peptide-1 receptor agonists on atrial fibrillation incidence: a systematic review and meta-analysis

Session: Atrial fibrillation management: from anticoagulation to SGLT2 inhibitors
Topic: Prevalence and Incidence of Atrial Fibrillation
Speaker: Mr K. Banerjee (London, GB)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Kushal Banerjee

London (United Kingdom of Great Britain & Northern Ireland)
0 follower

2 more presentations in this session

Impact of real-world off-label dose of apixaban on long-term clinical outcomes in heart failure patients with atrial fibrillation and end stage kidney disease

Speaker: Doctor S. Im (Pusan, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of cardiac damage on cardioversion success in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Doctor P. Wilke (Duesseldorf, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Atrial fibrillation management: from anticoagulation to SGLT2 inhibitors

Speakers: Mr K. Banerjee, Doctor S. Im, Doctor P. Wilke
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources